Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax

被引:22
作者
de Oliveira, CI
Wunderlich, G
Levitus, G
Soares, IS
Rodrigues, MM
Tsuji, M
del Portillo, HA
机构
[1] Univ Sao Paulo, Inst Ciencias Biomed 2, Dept Parasitol, BR-05508900 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil
[3] NYU, Med Ctr, Dept Med & Mol Pharmacol, New York, NY USA
基金
巴西圣保罗研究基金会;
关键词
Plasmodium vivax; merozoite surface protein 1; DNA vaccines;
D O I
10.1016/S0264-410X(99)00176-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmodium vivax is responsible for an approximate 35 million yearly human cases of malaria. Unfortunately, due to the low mortality rate associated with it and the difficulties of continuously in vitro culturing of this parasite, vaccine development against this human malaria has been largely neglected. In here, the antigenic properties of the merozoite surface protein 1 gene of P. vivax (PvMSP-1), were studied. Thus, seven recombinant bacterial plasmids coding different regions of the PvMSP-1 protein were constructed and used to immunize BALB/c mice, The results demonstrated that a plasmid encoding the entire N-terminus comprising 682 amino acids and a plasmid encoding the C-terminus including the two juxtaposed epidermal growth factor (EGF)-like domains fused to the Hepatitis B surface antigen, were antigenic. Moreover, the elicited immune responses were similar to those reported for these same PvMSP-1 regions in natural human infections. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2959 / 2968
页数:10
相关论文
共 43 条
[1]   Nucleic acid vaccination against Toxoplasma gondii in mice [J].
Angus, CW ;
Klivington, D ;
Wyman, J ;
Kovacs, JA .
JOURNAL OF EUKARYOTIC MICROBIOLOGY, 1996, 43 (05) :S117-S117
[2]   Protection of mice against Plasmodium yoelii sporozoite challenge with P-yoelii merozoite surface protein 1 DNA vaccines [J].
Becker, SI ;
Wang, RB ;
Hedstrom, RC ;
Aguiar, JC ;
Jones, TR ;
Hoffman, SL ;
Gardner, MJ .
INFECTION AND IMMUNITY, 1998, 66 (07) :3457-3461
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   A recombinant Baculovirus 42-kilodalton c-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria [J].
Chang, SP ;
Case, SE ;
Gosnell, WL ;
Kramer, KJ ;
Tam, LQ ;
Hashiro, CQ ;
Nikaido, CM ;
Gibson, HL ;
LeeNg, CT ;
Barr, PJ ;
Yokota, BT ;
Hui, GSN .
INFECTION AND IMMUNITY, 1996, 64 (01) :253-261
[5]   IMMUNIZATION WITH SYNTHETIC PEPTIDES OF A PLASMODIUM-FALCIPARUM SURFACE-ANTIGEN INDUCES ANTIMEROZOITE ANTIBODIES [J].
CHEUNG, A ;
LEBAN, J ;
SHAW, AR ;
MERKLI, B ;
STOCKER, J ;
CHIZZOLINI, C ;
SANDER, C ;
PERRIN, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) :8328-8332
[6]   Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice [J].
Costa, F ;
Franchin, G ;
Pereira-Chioccola, VL ;
Ribeiräo, M ;
Schenkman, S ;
Rodrigues, MM .
VACCINE, 1998, 16 (08) :768-774
[7]  
DALY TM, 1995, J IMMUNOL, V155, P236
[8]   PLASMODIUM-VIVAX MALARIA - PARASITE BIOLOGY DEFINES POTENTIAL TARGETS FOR VACCINE DEVELOPMENT [J].
DAVID, PH ;
DELPORTILLO, HA ;
MENDIS, KN .
BIOLOGY OF THE CELL, 1988, 64 (02) :251-260
[9]   PRIMARY STRUCTURE OF THE MEROZOITE SURFACE ANTIGEN-1 OF PLASMODIUM-VIVAX REVEALS SEQUENCES CONSERVED BETWEEN DIFFERENT PLASMODIUM SPECIES [J].
DELPORTILLO, HA ;
LONGACRE, S ;
KHOURI, E ;
DAVID, PH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :4030-4034
[10]   Induction of protective immunity to Theileria annulata using two major merozite surface antigens presented by different delivery systems [J].
dOliveira, C ;
Feenstra, A ;
Vos, H ;
Osterhaus, ADME ;
Shiels, BR ;
Cornelissen, AWCA ;
Jongejan, F .
VACCINE, 1997, 15 (16) :1796-1804